Inari VISION Registry

August 10, 2026 updated by: Inari Medical
This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Italy
      • Ancona, Italy
        • Recruiting
        • Azienda Ospedaliero Universitaria delle Marche
        • Contact:
          • Tommaso Piva, MD
  • Portugal
      • Lisbon, Portugal
        • Recruiting
        • Santa Marta Hospital
        • Contact:
          • Luís Almeida Morais, MD
  • United Kingdom
      • Bristol, United Kingdom
        • Recruiting
        • Southmead Hospital Bristol
        • Contact:
          • Peter Mezes, MD
      • Glasgow, United Kingdom
        • Recruiting
        • Queen Elizabeth University Hospital
        • Contact:
          • Peter Douglas, MBChB
      • London, United Kingdom
        • Recruiting
        • Royal Free Hospital
        • Contact:
          • Tushar Kotecha, PhD
      • London, United Kingdom
        • Recruiting
        • Northwick Park Hospital
        • Contact:
          • Jaymin Shah, MD
      • London, United Kingdom
        • Recruiting
        • UCLH University College London Hospital
        • Contact:
          • Conrad von Stempel, MBBS
      • London, United Kingdom
        • Recruiting
        • Royal London
        • Contact:
          • Rashid Akhtar, MBBS
      • Newcastle, United Kingdom
        • Recruiting
        • Royal Victoria Infirmary
        • Contact:
          • John Reicher, BM BCh
      • Swindon, United Kingdom
        • Recruiting
        • Great Western Hospital
        • Contact:
          • Steve Ramcharitar, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who have been treated with an Inari Medical device.

Description

Inclusion Criteria:

  1. Willing and able to provide informed consent per institution and geographical requirements
  2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure.
  3. Currently within enrollment window relative to their procedure
  4. Age ≥ 18 years

Exclusion Criteria:

  1. Is or will be inaccessible for registry follow-up
  2. Meets exclusion criteria required by local requirements
  3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry
  4. Is pregnant or breastfeeding at the time of enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incidence of device-related, procedure-related, or fatal Adverse Events
Time Frame: Up to 180 days
Up to 180 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Inari Medical

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2025

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2029

Study Registration Dates

First Submitted

August 15, 2024

First Submitted That Met QC Criteria

September 16, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

August 11, 2026

Last Update Submitted That Met QC Criteria

August 10, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 24-003

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe